Showing results (811-820 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|May 20, 2022
Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)John R Apps, Shanna Maycock, David W Ellison, et al.
Neuro-Oncology Advances|May 20, 2022
Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based studyRaoull Hoogendijk, Jasper van der Lugt, Dannis van Vuurden, et al.
Neuro-Oncology Advances|June 16, 2021
The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastomaAntonio Dono, Arvind V Ramesh, Emily Wang, et al.
Neuro-Oncology Advances|May 22, 2023
Current approaches in enhancing TRAIL therapies in glioblastomaMorrent Thang, Clara Mellows, Alison Mercer-Smith, et al.
Neuro-Oncology Advances|May 22, 2023
UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic diseaseEunice Paisana, Rita Cascão, Carlos Custódia, et al.
Neuro-Oncology Advances|May 22, 2023
Convection-enhanced delivery of immunomodulatory therapy for high-grade gliomaColin P Sperring, Michael G Argenziano, William M Savage, et al.
Neuro-Oncology Advances|October 15, 2019
A comprehensive preclinical assessment of late-term imaging markers of radiation-induced brain injuryTien T Tang, Janice A Zawaski, Shelli R Kesler, et al.
Neuro-Oncology Advances|March 18, 2022
An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effectFarah Rahal, Caroline Capdevielle, Benoit Rousseau, et al.
Pageof 138